Pfizer Inc. and BioNTech SE declared on Wednesday that their coronavirus vaccine applicant showed 95% efficacy in preventing the virus after final data analysis.
Meanwhile, the vaccine demonstrated over 94% effective among elderly participants in late-stage trials who are at high risk of suffering from a severe illness that may be generated by the virus.
Pfizer also unveiled that it intends to submit an application for emergency use authorization to the United States Food and Drug Administration (FDA) “within days.”
The Tunisair flight TU999, scheduled to depart from Nice at 16:35 (French time) on April…
The New York Times has released a video showing the killing of aid workers in…
The Criminal Division of the Tunis Court of Appeal found the defendants guilty in the…
A new seismic tremor measuring 3.1 on the Richter scale was recorded on Saturday at…
An Unprecedented Alert in the Tech World An influential voice from Silicon Valley is sounding…
The Jendouba Governorate has taken a significant step toward improving healthcare services by equipping the…
This website uses cookies.